1. Home
  2. TEVA vs GFI Comparison

TEVA vs GFI Comparison

Compare TEVA & GFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • GFI
  • Stock Information
  • Founded
  • TEVA 1901
  • GFI 1887
  • Country
  • TEVA Israel
  • GFI South Africa
  • Employees
  • TEVA N/A
  • GFI N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • GFI Precious Metals
  • Sector
  • TEVA Health Care
  • GFI Basic Materials
  • Exchange
  • TEVA Nasdaq
  • GFI Nasdaq
  • Market Cap
  • TEVA 20.1B
  • GFI 20.5B
  • IPO Year
  • TEVA N/A
  • GFI 2007
  • Fundamental
  • Price
  • TEVA $16.76
  • GFI $23.61
  • Analyst Decision
  • TEVA Strong Buy
  • GFI Hold
  • Analyst Count
  • TEVA 8
  • GFI 3
  • Target Price
  • TEVA $24.50
  • GFI $20.93
  • AVG Volume (30 Days)
  • TEVA 10.1M
  • GFI 2.9M
  • Earning Date
  • TEVA 07-30-2025
  • GFI 08-22-2025
  • Dividend Yield
  • TEVA N/A
  • GFI 1.79%
  • EPS Growth
  • TEVA N/A
  • GFI 78.24
  • EPS
  • TEVA N/A
  • GFI 1.38
  • Revenue
  • TEVA $16,616,000,000.00
  • GFI $5,201,600,000.00
  • Revenue This Year
  • TEVA $5.69
  • GFI $39.63
  • Revenue Next Year
  • TEVA N/A
  • GFI $13.08
  • P/E Ratio
  • TEVA N/A
  • GFI $17.53
  • Revenue Growth
  • TEVA 3.82
  • GFI 15.57
  • 52 Week Low
  • TEVA $12.47
  • GFI $12.98
  • 52 Week High
  • TEVA $22.80
  • GFI $26.36
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 47.80
  • GFI 51.72
  • Support Level
  • TEVA $16.55
  • GFI $23.75
  • Resistance Level
  • TEVA $17.30
  • GFI $24.83
  • Average True Range (ATR)
  • TEVA 0.39
  • GFI 0.64
  • MACD
  • TEVA -0.05
  • GFI -0.06
  • Stochastic Oscillator
  • TEVA 38.89
  • GFI 67.35

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About GFI Gold Fields Limited

Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.

Share on Social Networks: